Use of mutant 125I-Perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells
暂无分享,去创建一个
[1] T. Steck,et al. Circulation of Cholesterol between Lysosomes and the Plasma Membrane* , 1998, The Journal of Biological Chemistry.
[2] J. Flanagan,et al. Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding. , 2009, Biochemistry.
[3] Y. Lange. Tracking cell cholesterol with cholesterol oxidase. , 1992, Journal of lipid research.
[4] M. Brown,et al. The LDL receptor locus and the genetics of familial hypercholesterolemia. , 1979, Annual review of genetics.
[5] L. Liscum,et al. Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. , 1996, Journal of lipid research.
[6] J. McDonald,et al. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. , 2008, Cell metabolism.
[7] L. Liscum,et al. Evidence for a Cholesterol Transport Pathway from Lysosomes to Endoplasmic Reticulum That Is Independent of the Plasma Membrane* , 1998, The Journal of Biological Chemistry.
[8] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[9] Y. Shimada,et al. Cholesterol-binding toxins and anti-cholesterol antibodies as structural probes for cholesterol localization. , 2010, Sub-cellular biochemistry.
[10] L. Liscum,et al. The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts , 1989, The Journal of cell biology.
[11] G. Gimpl,et al. Probes for studying cholesterol binding and cell biology , 2011, Steroids.
[12] J. Goldstein,et al. The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.
[13] C deDuve,et al. Tissue fractionation. Past and present. , 1971 .
[14] D. Russell,et al. The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA , 1984, Cell.
[15] Y. Shimada,et al. The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. , 2002, European journal of biochemistry.
[16] L. Liscum,et al. Intracellular cholesterol transport. , 1999, Biochimica et biophysica acta.
[17] A. Radhakrishnan,et al. Accessibility of Cholesterol in Endoplasmic Reticulum Membranes and Activation of SREBP-2 Switch Abruptly at a Common Cholesterol Threshold , 2010, The Journal of Biological Chemistry.
[18] J. Goldstein,et al. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. , 2002, Molecular cell.
[19] D. Czajkowsky,et al. Monomer-Monomer Interactions Drive the Prepore to Pore Conversion of a β-Barrel-forming Cholesterol-dependent Cytolysin* , 2002, The Journal of Biological Chemistry.
[20] R. Aebersold,et al. Crucial Step in Cholesterol Homeostasis Sterols Promote Binding of SCAP to INSIG-1, a Membrane Protein that Facilitates Retention of SREBPs in ER , 2002, Cell.
[21] R. Brady,et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Brown,et al. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.
[23] Christian de Duve,et al. Tissue fraction-past and present. , 1971 .
[24] E. Goldberg,et al. Lactate dehydrogenase isozymes from mouse. , 1982, Methods in enzymology.
[25] Toshihide Kobayashi,et al. Fluorescence image screening for chemical compounds modifying cholesterol metabolism and distribution[S] , 2011, Journal of Lipid Research.
[26] M. Brown,et al. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. , 1978, The Journal of biological chemistry.
[27] J. Goldstein,et al. Regulation of the mevalonate pathway , 1990, Nature.
[28] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[29] M. Brown,et al. Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. , 1976, The Journal of biological chemistry.
[30] M. Swaisgood,et al. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. , 1989, The Journal of biological chemistry.
[31] M. Brown,et al. Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339. , 1975, The Journal of biological chemistry.
[32] C. Korzeniewski,et al. An enzyme-release assay for natural cytotoxicity. , 1983, Journal of immunological methods.
[33] E. London,et al. How Interaction of Perfringolysin O with Membranes Is Controlled by Sterol Structure, Lipid Structure, and Physiological Low pH , 2008, Journal of Biological Chemistry.
[34] W. J. Johnson,et al. Cellular Cholesterol Efflux Mediated by Cyclodextrins (*) , 1995, The Journal of Biological Chemistry.
[35] B. Wattenberg,et al. Sterol partitioning among intracellular membranes. Testing a model for cellular sterol distribution. , 1983, The Journal of biological chemistry.